Pemilik
Lihat sahaja
Muat Naik & Edit 
Ahli-ahli hanya boleh melihat item-item di dalam folder ini.
Ahli-ahli boleh melihat, menambah, mengedit dan memadam item-item di dalam folder ini.

RECUPERADOS

oleh  diogoqueroz18 71,201 KB • 61 fail-fail

Laporkan Penyalahgunaan
Muat turun sebagai Zip
Tambah pada akaun saya
 
Nama Saiz Tarikh Ditambah Tambah ke akaun
A PPAR-gamma agonist attenuates pulmonary injury induced byirradiation in a murine model.pdf
A PPAR-gamma agonist attenuates pulmonary injury induced byirradiation in a murine model.pdf
A radioterapia é uma estratégia terapêutica que utiliza radiação ionizante (RI) para.docx
A radioterapia é uma estratégia terapêutica que utiliza radiação ionizante (RI) para.docx
A Role for the PPARγ in Cancer Therapy.pdf
A Role for the PPARγ in Cancer Therapy.pdf
ADMINISTRATION OF THE PEROXISOMAL PROLIFERATOR-ACTIVATED.pdf
ADMINISTRATION OF THE PEROXISOMAL PROLIFERATOR-ACTIVATED.pdf
análise dos parametros apoptóticos em linfócitos humanos.pdf
análise dos parametros apoptóticos em linfócitos humanos.pdf
aplicação da citogenética na avalia;'ao.pdf
aplicação da citogenética na avalia;'ao.pdf
BEIR VII.pdf
BEIR VII.pdf
caudia_araujo_ioc_mest_2012.pdf
caudia_araujo_ioc_mest_2012.pdf
DEFINING MOLECULAR AND CELLULAR RESPONSES AFTER LOW AND HIGH LINEAR ENERGY TRANSFER RADIATIONS TO DEVELOP BIOMARKERS OF CARCINOGENIC RISK OR THERAPEUTIC OUTCOME.pdf
DEFINING MOLECULAR AND CELLULAR RESPONSES AFTER LOW AND HIGH LINEAR ENERGY TRANSFER RADIATIONS TO DEVELOP BIOMARKERS OF CARCINOGENIC RISK OR THERAPEUTIC OUTCOME.pdf
Diabetes melito, tiazolidinedionas e fraturas- uma história inacabada.pdf
Diabetes melito, tiazolidinedionas e fraturas- uma história inacabada.pdf
Diabetes melito, tiazolidinedionas e.pdf
Diabetes melito, tiazolidinedionas e.pdf
Dissertação Thaisa Feliciano de Souza.pdf
Dissertação Thaisa Feliciano de Souza.pdf
EcR names.pdf
EcR names.pdf
Efeitos de novos derivados tiazolidínicos agonistas.pdf
Efeitos de novos derivados tiazolidínicos agonistas.pdf
Estudo do envolvimento do receptor nuclear PPARγ na sepse experimental.pdf
Estudo do envolvimento do receptor nuclear PPARγ na sepse experimental.pdf
Future Strategies for Mitigation and Treatment.pdf
Future Strategies for Mitigation and Treatment.pdf
Glossary.pdf
Glossary.pdf
GQ-16, a Novel Peroxisome Proliferator-activated Receptor .pdf
GQ-16, a Novel Peroxisome Proliferator-activated Receptor .pdf
GQ-16, a Novel Peroxisome Proliferator-activated Receptor.pdf
GQ-16, a Novel Peroxisome Proliferator-activated Receptor.pdf
GQ-16, AGONISTA PARCIAL DE PPARγ,.pdf
GQ-16, AGONISTA PARCIAL DE PPARγ,.pdf
IMPORTÂNCIA DO CONHECIMENTO SOBRE RADIOPROTEÇÃO.pdf
IMPORTÂNCIA DO CONHECIMENTO SOBRE RADIOPROTEÇÃO.pdf
LXR.pdf
LXR.pdf
Mariana Brayner.pdf
Mariana Brayner.pdf
Mechanisms of injury to normal tissue after radiotherapy.pdf
Mechanisms of injury to normal tissue after radiotherapy.pdf
Modelo animal de doença critérios de escolha e espécies.pdf
Modelo animal de doença critérios de escolha e espécies.pdf
Multiplex Bead Array Assays Performance Evaluation and.pdf
Multiplex Bead Array Assays Performance Evaluation and.pdf
Natural product agonists of peroxisome proliferator-activated.pdf
Natural product agonists of peroxisome proliferator-activated.pdf
Normal cellular radiosensitivity in an adult Fanconi anaemia patient with.pdf
Normal cellular radiosensitivity in an adult Fanconi anaemia patient with.pdf
Normal Tissue Radiosensitivity - How Important Is It.pdf
Normal Tissue Radiosensitivity - How Important Is It.pdf
Normal tissue reactions to radiotherapy.pdf
Normal tissue reactions to radiotherapy.pdf

Lihat fail 30 office di folder RECUPERADOS 4shared saya

Terma Penggunaan
Privasi
Sokongan
Jangan jual maklumat peribadi saya
Jangan kongsi maklumat peribadi saya
Versi Mudah Alih
• Bahasa Melayu
Deutsch
हिंदी
Русский
한국어
Bahasa Indonesia
Português (Brasil)
English
Italiano
Français
Español
中文
العربية
Tiếng Việt
ไทย
Українська
日本語
Tagalog
پارسی
Polski
Türkçe
Kami Menggunakan Kuki. 4shared menggunakan kuki dan teknologi penjejakan lain untuk memahami dari mana pengunjung kami datang dan meningkatkan pengalaman melayari Anda di Laman Web kami. Dengan menggunakan Laman Web kami, Anda bersetuju dengan penggunaan kuki dan teknologi penjejakan lain oleh kami. Ubah pilihan saya
Saya Setuju